Caption Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $382,836 - $584,496	-35,317 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.69 - $21.14 $554,123 - $746,601	35,317 New	35,317 $554,000
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $309,120 - $384,640	-32,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $135,000 - $302,400	18,000 Added 128.57%	32,000 $332,000
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $173,320 - $244,579	14,000 New	14,000 $230,000

161

45.3M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $283M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.